Orion
Search documents
Orion’s FY’25 Gross Margin Increased to 25.4% (+230 bps) on Revenue of $79.7M; Expects 5% Revenue Growth and Improved Bottom Line Performance in FY’26; Call Today at 10am ET
Globenewswire· 2025-06-26 10:59
Core Insights - Orion Energy Systems, Inc. reported Q4'25 revenue of $20.9 million, a decrease of 21% from $26.4 million in Q4'24, primarily due to lower LED lighting revenue and maintenance services [2][4] - For FY'25, total revenue was $79.7 million, down 12% from $90.6 million in FY'24, with a notable 37% increase in EV charging revenue [4][5] - The company anticipates FY'26 revenue growth of approximately 5% to around $84 million, supported by improved operating costs and gross profit margins [4][11] Financial Performance - Q4'25 LED lighting revenue was $10.9 million, down 33% from $16.3 million in Q4'24, while EV charging revenue increased by 18% to $5.8 million [2][14] - Maintenance revenue in Q4'25 was $4.1 million, a decrease of 21% from $5.2 million in Q4'24, reflecting the elimination of unprofitable contracts [2][14] - Gross profit for Q4'25 was $5.7 million, with a gross profit margin of 27.5%, an increase of 170 basis points from 25.8% in Q4'24 [2][14] Operational Highlights - The company achieved positive adjusted EBITDA in Q4'25 and improved its cash position to $6.0 million, up from $5.2 million at the end of FY'24 [4][8] - Orion has made significant progress in reducing operating expenses, with a reduction of over $4 million in FY'25 and plans for an additional $1.5 million in FY'26 [4][7] - Strong bookings in late Q4'25 included new LED lighting engagements with a potential five-year revenue of $100 million to $200 million [4][6] Strategic Initiatives - Orion has reorganized into two Commercial Business Units (CBUs): Solutions and Partners, to better align with customer needs and enhance revenue visibility [4][9] - The company is focusing on channel partner engagement and has added an industry veteran to boost sales capabilities starting in Q2'26 [4][6] - Orion's liquidity position has been enhanced through a binding term sheet regarding Voltrek acquisition earnout payments, which includes a mix of common stock and a subordinated note [4][20] Future Outlook - The initial FY'26 outlook anticipates revenue growth of approximately 5% to $84 million, with expectations of approaching positive adjusted EBITDA for the full fiscal year [4][11] - Key contracts expected to contribute to FY'26 include a multi-year LED lighting retrofit contract with revenue potential of $12 million to $18 million [11][12] - The company expects modest growth in electrical maintenance revenues and a strong EV charging backlog, although near-term revenue from EV charging may be flat to slightly lower [15][17]
Orion(OESX) - 2025 Q3 - Earnings Call Presentation
2025-06-25 11:09
Company Overview - Orion Energy Systems focuses on helping customers achieve sustainability, energy savings, and carbon footprint reduction goals through innovative technology and service[6] - The company operates in lighting (retrofit), EV charging, and maintenance segments, serving various vertical markets like industrial, commercial, retail, and public sectors[15] - Orion offers turnkey solutions, product sales, maintenance services, and EV charging installations[15] Lighting Business - The lighting business has completed over 25,000 projects with a strong focus on commercial & industrial retrofit business[20] - Orion's Wisconsin manufacturing facility has an area of 266,000 square feet[22, 25] - The company provides substantial reduction in energy costs with an average payback of 1-4 years[23] - The average lead time for lighting products is 10-15 business days[38] Maintenance Business - The maintenance unit, acquired from Stay-Lite Lighting in January 2022, has 50 years of experience and serves 8000+ customer locations throughout the US and Caribbean[54] - The maintenance services include preventative and reactive lighting and electrical services[54] EV Charging Business - Orion acquired Voltrek in October 2022, a premier reseller of leading EV charging stations[60] - Voltrek manages 4000+ charging ports and offers turnkey, full-service solutions for EV charging installations[60] - A project example is the Boston Public Schools EV Bus Pilot, supporting the electrification of 20 out of 100 buses with a $15 million project[72, 78] Market Opportunity - The estimated market size for commercial & industrial lighting is projected to reach $807 billion in 2025, $1036 billion in 2030, and $1153 billion in 2035[52] - The high & low bay and linear submarket is estimated to reach $523 billion in 2025, $730 billion in 2030, and $825 billion in 2035[52] Financial Data - Revenue for FY24 was $906 million, and Last Twelve Months Q3 FY25 was $853 million[87] - Gross Margin % for FY24 was 231%, and Last Twelve Months Q3 FY25 was 251%[89] - Liquidity increased from $04 million in Q3 FY24 to $156 million in Q3 FY25[91]
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
Globenewswire· 2025-06-17 06:00
Core Insights - Orion Corporation and Glykos Finland Oy have extended their research collaboration and licensing agreement for the development of next-generation antibody-drug conjugates (ADCs) [1] Group 1: Agreement Details - Under the extended agreement, Orion will gain access to Glykos' proprietary ADC technologies, allowing for the potential expansion into three additional programs beyond the initial three outlined in the previous agreement [2] - Orion will be responsible for target selection, research, development, and commercialization of up to three next-generation ADCs, focusing on solid tumors [2] - The financial terms for the new ADC projects remain consistent with the original agreement, including milestone payments and royalties for Glykos related to product sales [3] Group 2: Company Statements - Orion emphasizes the importance of this collaboration in leveraging advanced ADC technology to develop new treatment options for cancer patients, as stated by Professor Outi Vaarala, Executive Vice President at Orion [4] - Glykos highlights the potential of their ADC technology and the significance of Orion's expertise in cancer therapies for effective treatment development, as mentioned by CEO Juhani Saarinen [5] Group 3: Company Background - Orion is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing pharmaceuticals and active pharmaceutical ingredients, particularly in oncology and pain [6] - Glykos specializes in ADCs, aiming to revolutionize cancer treatment with proprietary technology that enhances efficacy, tolerability, and pharmacokinetics [7]
LED Lighting, EV Charging Station and Electrical Maintenance Solutions Provider Orion Hosts Q4 Conference Call Thursday, June 26th at 10am ET
Globenewswire· 2025-06-05 12:28
Core Insights - Orion Energy Systems, Inc. will host a conference call and webcast to discuss its fourth quarter and fiscal 2025 results on June 26, 2025, at 10:00 a.m. ET, with results being released prior to market opening on the same day [1]. Group 1: Company Overview - Orion Energy Systems specializes in energy-efficient LED lighting, electrical vehicle charging solutions, and maintenance services [3]. - The company focuses on providing turnkey design-through-installation solutions for large national customers and projects through ESCO and distribution partners [3]. - Orion aims to help customers achieve their business, financial, and environmental goals with high-quality, innovative, and safe solutions, emphasizing customer service and reliability [3]. Group 2: Engagement and Communication - Orion encourages engagement through its social media platforms, including Twitter and StockTwits [4]. - Investor relations contacts are provided for further inquiries, including the CFO and representatives from Catalyst IR [4].
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
Globenewswire· 2025-06-03 20:30
Core Insights - The U.S. FDA has approved darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), marking the third indication for this drug [2][9] - The approval is based on the Phase III ARANOTE trial, which demonstrated a 46% reduction in the risk of radiological progression or death compared to placebo plus ADT [2][10] - Darolutamide is already approved in over 85 markets globally for various indications related to prostate cancer, including mHSPC and non-metastatic castration-resistant prostate cancer (nmCRPC) [5][6] Company Overview - Darolutamide, marketed as Nubeqa®, achieved blockbuster status with annual sales of EUR 1.52 billion reported by Bayer for the full year of 2024 [6] - The drug is developed jointly by Orion and Bayer, indicating a strong collaboration in the oncology sector [6][11] - Orion Corporation has a robust clinical development program for darolutamide, exploring its efficacy across various stages of prostate cancer [13] Industry Context - Prostate cancer is the second most common cancer in men, with an estimated 1.5 million diagnoses and approximately 397,000 deaths worldwide in 2022 [4] - The incidence of prostate cancer is projected to rise to 2.9 million by 2040, highlighting the growing need for effective treatment options [4] - The ARANOTE trial involved 669 patients and assessed the efficacy and safety of darolutamide plus ADT, reinforcing the drug's established safety profile [7][8]
海外AEM膜企业及产品一览
势银能链· 2025-05-28 03:25
Core Viewpoint - The article discusses the significance of anion exchange membranes (AEM) in the hydrogen production industry, highlighting key manufacturers and their product specifications, as well as upcoming industry events related to green hydrogen technology [3][5][6]. Group 1: Anion Exchange Membrane Overview - Anion exchange membranes are critical components of AEM electrolyzer systems, requiring excellent mechanical properties, low dimensional expansion, high conductivity, and outstanding chemical stability [3]. - Major overseas manufacturers of AEMs are located in the Asia-Pacific and North America, including companies like FuMa-Tech, Dioxide Materials, Versogen, and others [3]. Group 2: Performance Summary of AEMs - A summary table lists various AEM products, their thickness, ion exchange capacity, ionic conductivity, surface resistance, tensile strength, elongation at break, and water absorption rates [5]. - For example, FuMa-Tech's Fumasep FAA3-50 has a thickness of 45-55 micrometers, an ion exchange capacity of 1.6-2.0 meq/g, and a water absorption rate of 10-25% at 25°C [5]. Group 3: Industry Developments - Evonik announced plans to build a pilot production facility in Marl, Germany, for its DURAION® AEM, expected to be operational by the end of 2025, with an annual production capacity sufficient for 2.5 GW of hydrogen electrolyzer demand [5]. - NovaMea, established in 2023, focuses on advanced AEM and catalyst development, with its first production line in Suzhou expected to be operational by April 2025 [6]. - Greenlyzer, founded by a team from Dioxide Materials, aims to develop low-cost green hydrogen production technologies, with plans to launch a megawatt-level AEM electrolyzer product by 2025 [6].
Orion (OEC) Lags Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-08 00:55
Financial Performance - Orion reported quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.53 per share, and down from $0.52 per share a year ago, representing an earnings surprise of -58.49% [1] - The company posted revenues of $477.7 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.69%, and down from $502.9 million year-over-year [2] - Over the last four quarters, Orion has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates during the same period [2] Stock Performance - Orion shares have declined approximately 27.4% since the beginning of the year, compared to a decline of -4.7% for the S&P 500 [3] - The current Zacks Rank for Orion is 4 (Sell), indicating expectations for the stock to underperform the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.43 on revenues of $477.53 million, and for the current fiscal year, it is $1.60 on revenues of $1.86 billion [7] - The trend for estimate revisions ahead of the earnings release was unfavorable, which may impact future stock performance [6] Industry Context - The Chemical - Specialty industry, to which Orion belongs, is currently ranked in the bottom 44% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Another company in the same industry, CSW Industrials, is expected to report quarterly earnings of $2.23 per share, reflecting a year-over-year change of +9.3% [9]
Orion’s USA Manufactured LED Lighting Fixtures Will Be Showcased at LightFair in Las Vegas May 6-8
Globenewswire· 2025-04-24 12:27
Core Viewpoint - Orion Energy Systems, Inc. is showcasing its high-quality, USA-manufactured LED lighting products at LightFair 2025, emphasizing its commitment to quality and innovation amidst industry challenges [1][3]. Company Overview - Orion specializes in energy-efficient solutions, including LED lighting, EV charging stations, and electrical maintenance services, focusing on helping customers achieve business and environmental goals [5]. - The company offers turnkey design-through-installation solutions for large national customers and works with ESCO and distribution partners [5]. Product Highlights - Orion's LED lighting fixtures are noted for their high quality and performance, contrasting with competitors who are increasing prices and lead times [2]. - The company emphasizes its flexible supply chain, which allows it to meet market demands effectively [2]. Industry Context - Orion's products are not affected by current tariff-related volatility, positioning the company favorably in the market [3]. - The company is committed to manufacturing in Wisconsin, reinforcing its dedication to local production and quality [3]. Investor Engagement - An informal investor gathering will be held on May 6 at LightFair, providing an opportunity for investors to meet the CEO and learn more about the company [4].
Tenax Therapeutics(TENX) - Prospectus(update)
2024-02-01 21:20
S-1/A 1 tenx_s1a.htm FORM S-1/A As filed with the U.S. Securities and Exchange Commission on February 1, 2024 Registration No. 333-275856 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tenax Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2593535 (Primary Standard Industrial Classification Code Nu ...
Orion(OESX) - 2022 Q4 - Earnings Call Presentation
2022-06-07 13:19
Mike Altschaefl, CEO Per Brodin, CFO Mike Jenkins, COO Providing energy saving LED lighting systems and turnkey project implementation ir@oesx.com www.orionlighting.com OLION ORION ENERGY SYSTEMS, INC. NASDAQ: OESX SAFE HARBOR Certain matters discussed in this press release, including under the heading "Outlook" are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may gene ...